지엔티파마 GedaCure 승인 글로벌 보도자료
페이지 정보
작성자 GNTPharma
조회 10,309회 작성일 2021-02-25 16:53
본문
GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome
https://www.businesswire.com/news/home/20210210005036/en
GedaCure® von GNT Pharma für die Behandlung von Hunden mit kognitiven Funktionsstörungen zugelassen
https://www.businesswire.com/news/home/20210210005254/de/
Le GedaCure® de GNT Pharma est approuvé pour le traitement des chiens atteints du syndrome de dysfonctionnement cognitif
https://www.businesswire.com/news/home/20210210005041/fr/
Se aprueba GedaCure® de GNT Pharma para el tratamiento de perros con síndrome de disfunción cognitiva
https://www.businesswire.com/news/home/20210210005037/es/
GedaCure® da GNT Pharma aprovado para o tratamento de cães com síndrome de disfunção cognitiva
https://www.businesswire.com/news/home/20210210005039/pt/
GedaCure® di GNT Pharma approvato per il trattamento di cani con sindrome da disfunzione cognitiva
https://www.businesswire.com/news/home/20210210005038/it/
GedaCure® van GNT Pharma goedgekeurd voor de behandeling van honden met cognitief disfunctiesyndroom
https://www.businesswire.com/news/home/20210210005044/nl/
GNTファーマのGedaCure®が犬の認知障害症候群の治療薬として承認される
https://www.businesswire.com/news/home/20210210005040/ja/
GNT Pharma的GedaCure®获准用于治疗犬类认知功能障碍综合征
https://www.businesswire.com/news/home/20210210005042/zh-CN/
GNT Pharma的GedaCure®獲准用於治療犬類認知功能障礙症候群
https://www.businesswire.com/news/home/20210210005043/zh-HK/
عقار جيداكيور ®GedaCure من جي إن تي فارما يحظى بالموافقة لعلاج الكلاب المصابة بمتلازمة الخلل الوظيفي الإدراكي
https://bit.ly/3rLs37N